Guillain-barré syndrome and 1978–79 influenza vaccine

1981 ◽  
Vol 3 (5) ◽  
pp. 34
Neurology ◽  
2000 ◽  
Vol 55 (3) ◽  
pp. 452-453 ◽  
Author(s):  
E. F. M. Wijdicks ◽  
D. D. Fletcher ◽  
N. D. Lawn

Vaccine ◽  
2015 ◽  
Vol 33 (17) ◽  
pp. 2045-2049 ◽  
Author(s):  
Shahed Iqbal ◽  
Rongxia Li ◽  
Paul Gargiullo ◽  
Claudia Vellozzi

2019 ◽  
Vol 10 (10.2) ◽  
pp. 98-102 ◽  
Author(s):  
Mihai Sava ◽  
Maria-Gabriela Catană ◽  
Corina Roman-Filip

Abstract Guillain-Barre syndrome (GBS) is the most common cause of acute flaccid paralysis worldwide, having an incidence of about 1/100,000 across several studies in a number of countries. We present the case of a 60-year-old female patient, with known hypertension, admitted to our department for paresthesia and muscle weakness predominantly in the distal upper and lower limbs. Symptomatology had an acute onset after 14 days from influenza vaccine administration. Lumbar puncture revealed CSF glucose (91 mg/dl), CSF protein (0.508 g/l) and no pleocytosis. Electromyography supported the presumptive diagnosis of polyradiculoneuritis. The patient underwent three sessions of double filtration and the final diagnosis was Guillain-Barre polyradiculoneuritis secondary to influenza vaccination. Approximately 80% of patients with polyradiculoneuritis recover completely within a few months to one year; however, 5-10% of these patients experience one or more recurrences. It should be emphasized that acute-phase rehabilitation must start immediately and include an individualized program of gentle strengthening, and manual resistive and progressive resistive exercises. Key words: polyradiculoneuropathy, influenza vaccine, neurorehabilitation,


2010 ◽  
Vol 39 (4) ◽  
pp. 296-304 ◽  
Author(s):  
Dale R. Burwen ◽  
Robert Ball ◽  
Wilson W. Bryan ◽  
Hector S. Izurieta ◽  
Lawrence La Voie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document